Product
Intermediate dose thromboprophylaxis
2 clinical trials
4 indications
Indication
COVID-19 Associated CoagulopathyIndication
Community-acquired PneumoniaIndication
InfluenzaIndication
COVID-19Clinical trial
COVID-19-associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults With COVID-19Status: Completed, Estimated PCD: 2021-04-16
Clinical trial
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaStatus: Recruiting, Estimated PCD: 2026-02-01